Sunifiram Anabolic Steroid Powder for Memory Enhancement

본문 바로가기
Home > Product > Sunifiram Anabolic Steroid Powder for Memory Enhancement
Selling leads
Sunifiram Anabolic Steroid Powder for Memory Enhancement
Posting date : Mar 25, 2017
Membership
Free Member Scince Mar 24, 2017
FOB Price
$1
Min. Order Quantity
20grams
Supply Abillity
5000KG/week
Port
Guangzhou
Payment Terms
T/T, Bank Transfer, Western Union, Paypal
Package
According to your requirements
Keyword :
SARMs
Category
Contact
Tont
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Kafen
Model Number
1379686-30-2
HS-CODE
-
Package & Delivery Lead Time
Package
According to your requirements
Delivery Lead Time
Within 12 hours after receiving your payment.
Detailed Description
 
Sunifiram Anabolic Steroid Powder for Memory Enhancement
Basic Info: CAS: 314728-85-3MF: C14H18N2O2MW: 246.30492Appearance: White powderPurity: 99.32%Shelf life: 2 yearsStandard: In-house StandardUsage: For the treatment of Alzheimers Dementia, Cognition Disorder, Neurologic Drugs, Senile Dementia, Acetylcholine Release Enhancers.  Product Description: This compound is known as an AMPAkine due to exerting most of its actions via the AMPA receptor (one of the three main subsets of glutamate receptors, alongside NDMA and kainate). This enhancement of AMPA function seems to also rely on enhancing signalling via the Glycine binding site of NMDA receptors, although one minimal signalling goes through the NMDA receptor then the benefits on AMPA receptors seem dose-dependent.
Sunifiram (DM-235) is a piperazine derived ampakine drug which acts as a positive allosteric modulator of AMPA receptors, and has nootropic effects in animal studies with significantly higher potency than piracetam. A number of related compounds are known, the best known being unifiram (DM-232).
This enhancement by sunifiram is associated with an increase inphosphorylation of AMPAR through activation of protein kinase II(CaMKII) and an increase in phosphorylation of NMDAR through activation of protein kinase C α (PKCα). More specifically, sunifiram stimulates the glycine-binding site of NMDAR with concomitant PKCαactivation through Src kinase. Enhancement of PKCα activity triggers to potentiate hippocampal LTP through CaMKII activation.Sunifiram improves cognitive deficits via CaM kinase II andprotein kinase C activation.  Application: For the treatment of Alzheimers Dementia, Cognition Disorder, Neurologic Drugs, Senile Dementia, Acetylcholine Release Enhancers.
Sunifiram (DM-235) is a synthetic derivative of Piracetam, although due to breaking the pyrrolidone backbone it is no longer in the Racetam class of drugs (yet by being derived from them, it is still commonly associated with this class).
Sunifiram has mechanisms similar to Nefiracetam in the hippocampus, and similar to that drug sunifiram shows anti-amnesiac properties and is potentially a cognitive enhancer. Its anti-amnesiac activity is several orders of magnitude greater than piracetam on a per weight basis, and preliminary evidence suggest it has a similarly low toxicity profile.  Function: Sunifiram increases energy levels, allowing users to feel more motivated and eliminate Sunifiram increase Levels of concentration increase, and users feel less distracted by external stimuli Sunifiram also enhances long-term potentiation, which is the forming of new connections regarding memory storage. Sunifiram has some anxiolytic benefits. Feeling more relaxed is beneficial when trying to focus.
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top